A novel noninvasive score including LSM by VCTE™ and routine clinical parameters improves the identification of cirrhosis among patients with MASLD and may reduce the necessity of liver biopsy in this patient population.
A novel noninvasive score including LSM by VCTE™ and routine clinical parameters improves the identification of cirrhosis among patients with MASLD and may reduce the necessity of liver biopsy in this patient population.
Inscrivez-vous à notre liste de diffusion pour recevoir des mises à jour sur les articles, des livres blancs et des webinaires de formation sur la prise en charge et le traitement des maladies chroniques du foie.